A citation-based method for searching scientific literature

Zhencong Ye, Yongmei Huang, Jianhao Ke, Xiao Zhu, Shuilong Leng, Hui Luo. Biomed Pharmacother 2021
Times Cited: 25







List of co-cited articles
53 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
28

piRNAs: biogenesis and their potential roles in cancer.
Binghong Guo, Dongpei Li, Likun Du, Xiao Zhu. Cancer Metastasis Rev 2020
57
20

How to overcome the side effects of tumor immunotherapy.
Shang Li, Zhibi Zhang, Wing-Fu Lai, Liao Cui, Xiao Zhu. Biomed Pharmacother 2020
19
26

Cancer immunotherapy: Pros, cons and beyond.
Shuzhen Tan, Dongpei Li, Xiao Zhu. Biomed Pharmacother 2020
124
20

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
16

New insights into molecules and pathways of cancer metabolism and therapeutic implications.
Zhenye Tang, Zhenhua Xu, Xiao Zhu, Jinfang Zhang. Cancer Commun (Lond) 2021
24
16

Circular RNAs: The star molecules in cancer.
Jianhong Liu, Dongpei Li, Hui Luo, Xiao Zhu. Mol Aspects Med 2019
100
16

The biology and management of non-small cell lung cancer.
Roy S Herbst, Daniel Morgensztern, Chris Boshoff. Nature 2018
16

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges.
Zhilin Zou, Tao Tao, Hongmei Li, Xiao Zhu. Cell Biosci 2020
172
12

The emerging roles of artificial intelligence in cancer drug development and precision therapy.
Guosheng Liang, Wenguo Fan, Hui Luo, Xiao Zhu. Biomed Pharmacother 2020
30
12


Cancer neoantigen: Boosting immunotherapy.
Peijia Xu, Haiqing Luo, Ying Kong, Wing-Fu Lai, Liao Cui, Xiao Zhu. Biomed Pharmacother 2020
22
13

Cancer Statistics, 2021.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
12

Cancer evolution: A means by which tumors evade treatment.
Xiao Zhu, Shi Li, Bairui Xu, Hui Luo. Biomed Pharmacother 2021
9
22


Tumor-infiltrating lymphocytes: Warriors fight against tumors powerfully.
Baisheng Lin, Likun Du, Hongmei Li, Xiao Zhu, Liao Cui, Xiaosong Li. Biomed Pharmacother 2020
27
8

A prognostic model guides surgical resection in cervical squamous cell carcinoma.
Baiqiang Liang, Haibing Yu, Lianfang Huang, Haiqing Luo, Xiao Zhu. Transl Cancer Res 2020
4
50

GWAS in cancer: progress and challenges.
Baiqiang Liang, Hongrong Ding, Lianfang Huang, Haiqing Luo, Xiao Zhu. Mol Genet Genomics 2020
34
8


The cancer exosomes: Clinical implications, applications and challenges.
Zhenye Tang, Dongpei Li, Shengping Hou, Xiao Zhu. Int J Cancer 2020
56
8

Big data-driven precision medicine: Starting the custom-made era of iatrology.
Chang Song, Ying Kong, Lianfang Huang, Hui Luo, Xiao Zhu. Biomed Pharmacother 2020
8
25

Nanomedicines: Redefining traditional medicine.
Weijia Lu, Jing Yao, Xiao Zhu, Yi Qi. Biomed Pharmacother 2021
21
9

RNA-based pharmacotherapy for tumors: From bench to clinic and back.
Xiangping Liang, Dongpei Li, Shuilong Leng, Xiao Zhu. Biomed Pharmacother 2020
35
8

Principles of RNA methylation and their implications for biology and medicine.
Yujia Zhou, Ying Kong, Wenguo Fan, Tao Tao, Qin Xiao, Na Li, Xiao Zhu. Biomed Pharmacother 2020
35
8

Genome-wide haplotype association study identifies risk genes for non-small cell lung cancer.
Yanbo Teng, Yanjun Ding, Mingming Zhang, Xinren Chen, Xizi Wang, Hang Yu, Chonghui Liu, Hongchao Lv, Ruijie Zhang. J Theor Biol 2018
6
33

Clinical application and mechanism of traditional Chinese medicine in treatment of lung cancer.
Xiao-Lin Su, Jiang-Wei Wang, Hui Che, Chang-Fu Wang, Hai Jiang, Xia Lei, Wan Zhao, Hai-Xue Kuang, Qiu-Hong Wang. Chin Med J (Engl) 2020
9
22

The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators.
Zhilin Zou, Shuguang Zhou, Guosheng Liang, Zhenye Tang, Kai Li, Shuzhen Tan, Xiangsheng Zhang, Xiao Zhu. Mol Omics 2021
8
25

Targeting the GRP78 Pathway for Cancer Therapy.
Guanhua Lu, Hui Luo, Xiao Zhu. Front Med (Lausanne) 2020
28
8


Clinical and Prognostic Pan-Cancer Analysis of N6-Methyladenosine Regulators in Two Types of Hematological Malignancies: A Retrospective Study Based on TCGA and GTEx Databases.
Xiangsheng Zhang, Liye Zhong, Zhilin Zou, Guosheng Liang, Zhenye Tang, Kai Li, Shuzhen Tan, Yongmei Huang, Xiao Zhu. Front Oncol 2021
11
18

Immunometabolism of regulatory T cells in cancer.
Mario Galgani, Sara Bruzzaniti, Claudia La Rocca, Teresa Micillo, Paola de Candia, Maurizio Bifulco, Giuseppe Matarese. Mol Aspects Med 2021
6
33

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.
Peng Jiang, Shengqing Gu, Deng Pan, Jingxin Fu, Avinash Sahu, Xihao Hu, Ziyi Li, Nicole Traugh, Xia Bu, Bo Li,[...]. Nat Med 2018
8

NK cells and ILCs in tumor immunotherapy.
Simona Sivori, Daniela Pende, Linda Quatrini, Gabriella Pietra, Mariella Della Chiesa, Paola Vacca, Nicola Tumino, Francesca Moretta, Maria Cristina Mingari, Franco Locatelli,[...]. Mol Aspects Med 2021
49
8

Wnt signaling pathway in non-small cell lung cancer.
David J Stewart. J Natl Cancer Inst 2014
414
8

CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
J L Hu, W Wang, X L Lan, Z C Zeng, Y S Liang, Y R Yan, F Y Song, F F Wang, X H Zhu, W J Liao,[...]. Mol Cancer 2019
255
8

Cancer statistics for the year 2020: An overview.
Jacques Ferlay, Murielle Colombet, Isabelle Soerjomataram, Donald M Parkin, Marion PiƱeros, Ariana Znaor, Freddie Bray. Int J Cancer 2021
585
8

A network pharmacology approach to investigate the blood enriching mechanism of Danggui buxue Decoction.
Xu-Qin Shi, Shi-Jun Yue, Yu-Ping Tang, Yan-Yan Chen, Gui-Sheng Zhou, Jing Zhang, Zhen-Hua Zhu, Pei Liu, Jin-Ao Duan. J Ethnopharmacol 2019
63
8

Controlled drug delivery vehicles for cancer treatment and their performance.
Sudipta Senapati, Arun Kumar Mahanta, Sunil Kumar, Pralay Maiti. Signal Transduct Target Ther 2018
613
8

mTOR Signaling in Growth, Metabolism, and Disease.
Robert A Saxton, David M Sabatini. Cell 2017
8

Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics.
Yunxia Wang, Song Zhang, Fengcheng Li, Ying Zhou, Ying Zhang, Zhengwen Wang, Runyuan Zhang, Jiang Zhu, Yuxiang Ren, Ying Tan,[...]. Nucleic Acids Res 2020
350
8

Non-small-cell lung cancer.
Cesare Gridelli, Antonio Rossi, David P Carbone, Juliana Guarize, Niki Karachaliou, Tony Mok, Francesco Petrella, Lorenzo Spaggiari, Rafael Rosell. Nat Rev Dis Primers 2015
369
8


A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitors.
Takaaki Sasaki, Jussi Koivunen, Atsuko Ogino, Masahiko Yanagita, Sarah Nikiforow, Wei Zheng, Christopher Lathan, J Paul Marcoux, Jinyan Du, Katsuhiro Okuda,[...]. Cancer Res 2011
451
8

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors.
Lecia V Sequist, Belinda A Waltman, Dora Dias-Santagata, Subba Digumarthy, Alexa B Turke, Panos Fidias, Kristin Bergethon, Alice T Shaw, Scott Gettinger, Arjola K Cosper,[...]. Sci Transl Med 2011
8

Understanding Suboptimal Response to Immune Checkpoint Inhibitors.
Mojun Zhu, Henan Zhang, Katrina S Pedersen, Nathan R Foster, Brandy L Jaszewski, Xin Liu, Jacob B Hirdler, Zesheng An, Tanios S Bekaii-Saab, Thorvardur R Halfdanarson,[...]. Adv Biol (Weinh) 2022
3
66



The metastasizing mechanisms of lung cancer: Recent advances and therapeutic challenges.
Shimin Xie, Zhengguo Wu, Yi Qi, Binhua Wu, Xiao Zhu. Biomed Pharmacother 2021
18
11

DNA methylation in lung cancer patients: Opening a "window of life" under precision medicine.
Runzhang Liang, Xiaosong Li, Weiquan Li, Xiao Zhu, Chen Li. Biomed Pharmacother 2021
17
11

Suppressive Myeloid Cells Shape the Tumor Immune Microenvironment.
Jia Xiong, Hui Wang, Qingqing Wang. Adv Biol (Weinh) 2021
6
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.